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INTRODUCTION
Intensity modulated radiation therapy (IMRT) is a new
approach to the planning and delivery of radiation (1, 2).
Unlike 2-dimensional radiotherapy (2D-RT) and 3-dimen-
sional radiotherapy (3D-CRT), IMRT allows more confor-
mal dose coverage of the clinical target volume (CTV) in
three dimensions, thereby sparing the surrounding normal
tissues. Highly conformal treatment plans may reduce the
risk of radiation toxicities and provide a means of potential-
ly escalating the dose to target in selected patients, thus im-
proving tumor control.
Head and neck cancers, especially nasopharyngeal cancer,
are good candidates for IMRT because of their horseshoe-
shaped CTVs and many critical normal organs that surround
the CTV (3). Improving the conformity of the radiation dose
to targets in the head and neck using IMRT promises reduced
toxicity and, in some cases, improved loco-regional tumor
control (3-7). Recently published phase III studies confirmed
that IMRT provides superior treatment results with lower
morbidity than conventional 2D- or 3D-CRT (8, 9).
IMRT may actually be disadvantageous in some situations,
however, because it is relatively difficult to plan and admin-
ister. The planning process for IMRT is greatly influenced
by physician-dependent factors such as segmentation of the
target volume and non-tumor tissues on the planning CT,
and specifying the dose to the target and the surrounding
normal organs. Although many hospitals are now equipped
with IMRT capabilities, the excellence of next level practice
achieved by the use of IMRT could differ among hospitals
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Multi-institutional Comparison of Intensity Modulated Radiation 
Therapy (IMRT) Planning Strategies and Planning Results for
Nasopharyngeal Cancer
The intensity-modulated radiation therapy (IMRT) planning strategies for nasopha-
ryngeal cancer among Korean radiation oncology facilities were investigated. Five
institutions with IMRT planning capacity using the same planning system were invit-
ed to participate in this study. The institutions were requested to produce the best
plan possible for 2 cases that would deliver 70 Gy to the planning target volume of
gross tumor (PTV1), 59.4 Gy to the PTV2, and 51.5 Gy to the PTV3 in which elec-
tive irradiation was required. The advised fractionation number was 33. The plan-
ning parameters, resultant dose distributions, and biological indices were compared.
We found 2-3-fold variations in the volume of treatment targets. Similar degree of
variation was found in the delineation of normal tissue. The physician-related fac-
tors in IMRT planning had more influence on the plan quality. The inhomogeneity
index of PTV dose ranged from 4 to 49% in Case 1, and from 5 to 46% in Case 2.
Variation in tumor control probabilities for the primary lesion and involved LNs was
less marked. Normal tissue complication probabilities for parotid glands and skin
showed marked variation. Results from this study suggest that greater efforts in
providing training and continuing education in terms of IMRT planning parameters
usually set by physician are necessary for the successful implementation of IMRT.
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ance; Nasopharyngeal Neoplasms
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Accepted : 26 June 2008depending on the clinical situation and the treatment team.
Preparedness in performing IMRT is a crucial factor in its
implementation.
In Korea, IMRT practices were established in several cen-
ters in 2001, and it is now being rapidly adopted. Accord-
ing to a 2006 survey conducted by the Korean Society for
Therapeutic Radiology and Oncology (KOSTRO), 22 of 61
(35%) radiotherapy facilities nationwide possessed the hard-
ware capacity necessary to implement IMRT practice (10).
Although several Korean facilities have undertaken planning
studies and explored the feasibility of IMRT in their clinic,
it appears that a lack of preparedness exists in terms of fully
implementing IMRT as a clinical routine (3, 4, 11-13). 
The purpose of the present study was to investigate IMRT
planning strategies for nasopharyngeal cancer among Kore-
an radiation oncology facilities. We compared the planning
parameters, resultant dose distributions, and values of bio-
logical indices, including normal tissue complication proba-
bilities (NTCP) and tumor control probabilities (TCP), with
a treatment plan generated in five different institutions using
the same radiation treatment planning system (RTPS) for
the same clinical cases. We also discussed the measures need-
ed to improve the degree of clinical excellence in implement-
ing IMRT as an advanced treatment technology. 
MATERIALS AND METHODS 
Study schemes
In May 2006, five institutions, all with the same RTPS
with IMRT planning capacity, were invited to participate in
this study. As planning images, contrast-enhanced comput-
ed tomography (CT) scans were provided for Case 1. For Case
2, both contrast-enhanced CT scans and positron emission
tomography (PET) images were provided. Planning images
for the study cases were obtained on a Discovery ST PET-CT
scanner (GE Healthcare, Milwaukee, WI, U.S.A.), using a
slice thickness of 0.37 cm, and with the patients immobilized
in the supine position using a Type S thermoplastic mask
(Medtec, Orange City, IA, U.S.A.). Planning images were
de-identified prior to use in the study. The employed IMRT
planning platform was the p3-IMRT inverse planning mod-
ule of Pinnacle3 (Philips, Fitchburg, WI, U.S.A.) commer-
cial RTPS. Back-up CD disks were prepared with the treat-
ment plans for the study cases; these plans had no added re-
gions of interests (ROIs), beams, or inverse planning param-
eters. The beam commissioning data for a standard linear
accelerator was added to these plans and used for dose calcu-
lations. We used the beam data of a Primus linear accelera-
tor (Siemens, Munich, Germany) housed at a participating
institution. 
Each institution received the back-up CDs. The plans for
the two clinical cases were restored in the RTPS of each insti-
tution. IMRT plans were performed in each institution accord-
ing to the study guidelines, up to the step of generating ideal
intensity maps for the beams. The treatment plans from each
institution were then compiled and restored in a planning
computer as different trials of the treatment planning data;
the data were then analyzed.
Treatment planning guidelines
The participating institutions were requested to produce
the best plan possible that would deliver 70 Gy to the plan-
ning target volume of gross tumor (PTV1), 59.4 Gy to the
region of high-risk regional lymph nodes (PTV2), and 51.5
Gy to the lymph node area (PTV3) in which elective irradi-
ation was required. The advised fractionation number was
33. Delineation of the target volume and normal organs, the
number and orientations of the beams, and the prescribed
number and type of dose constraints were left to the discre-
tion of the planning teams in each institution. 
Clinical cases
Case 1 was a 50-yr-old male diagnosed with cT2aN1 poorly
differentiated squamous cell carcinoma of the nasopharynx.
The primary tumor involved the right side of the Rosen-
mu_ller fossa and posterior wall of the nasopharynx, and ex-
tended to the posterior oropharyngeal wall. There was lymph
node (LN) metastasis to the right level 2 area. 
Case 2 was a 24-yr-old female diagnosed with T2bN2 un-
differentiated carcinoma of the nasopharynx. The primary
tumor involved the left side of the nasopharynx and extend-
ed to the parapharyngeal fatty tissues. There was tumor in-
volvement in the left-sided retropharyngeal LNs and bilat-
eral level 2 LNs. 
Plan comparison
IMRT planning strategies were compared. Parameters
compared in the planning process included the delineation
of target volume and normal organs, the number and orien-
tations of the beams, and the prescribed number and type of
dose constraints for optimization of the inverse planning. 
General features of the planning results were compared,
including the prescribed monitor unit (MU), maximum dose
and its location, inhomogeneity index of the dose distribution
to individual institution’s PTV, and the deviation of D50 from
the planning goal. The homogeneity index was defined as (D5-
D95)/(Dmean). Dvolume was defined as the dose level where the
cumulative dose volume histogram (DVH) intersects with
the given volume of the ROI. Dmean was defined as the mean
dose received by the ROI. The distributions of the isodose
curve and DVHs for individual institution’s PTV were also
compared.
The ROIs delineated by the institution that provided the
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clinical case were set as the standard ROIs. To avoid poten-
tial difficulties in comparing plans that might have risen had
ROIs been delineated separately by individual institutions,
both standard ROIs and individual institution’s ROIs were
used for the comparison of dose statistics and biological in-
dices among institutions. TCP was calculated via the Oku-
nieff model, using the values of the dose of 50% tumor con-
trol (TCD50), slope50, and γ 50 (14). NTCP was calculated via
the Lyman-Kutcher-Burman model, using the Kutcher-Bur-
man histogram reduction scheme, with n and m as deter-
mined by Burmann et al. (15, 16). 
RESULTS
Contouring of the ROIs
We found differences in the volumes contoured as the gross
tumor volume (GTV) of the primary tumor and the involved
LNs (Table 1). GTV of the primary tumor was 13.8-28.5 cm3
in Case 1, and 35.8-69.6 cm3in Case 2. The volumes of PTV1,
PTV2, and PTV3 were also different: we found 2-fold vari-
ation in the volume of PTV1, and a 3-fold variation in the
volume of PTV2. One institution did not delineate PTV3
in Case 1, and three institutions did not delineate PTV3 in
Case 2. This marked variation was due to difference in the
level of lymph node areas treated as high risk area, and those
treated as areas for elective nodal irradiation (Table 2). The
major difference among institutions consisted of whether they
decided to treat the level 1 and contralateral level 5 lymph
node areas. 
The variations encountered in contouring of the target vol-
umes are presented on the same axial CT slice (Fig. 1). The
contoured GTV for Case 2 was more consistent than that of
Case 1. Although the degree of volumetric differences was
the same in both cases, delineation of the GTV assisted by
PET images appeared to cover the gross tumor more consis-
tently, as in Case 2. For delineation of PTV2 and PTV3, al-
most all of the institutions used geometrical extension from
the margin of anatomical structures such as regional LN areas;
however, in constructing PTV2, Institution 2 used the direct
geometrical extension from PTV1 without consideration for
the anatomical margin of the regional LN area. 
A similar degree of variation was identified in the delin-
eation of normal tissue. All institutions delineated the pa-
rotid glands, eye balls, lens, optic nerve, and spinal cord. Not
all institutions delineated the brainstem, pituitary gland,
optic chiasm, oral cavity, trachea, esophagus, inner ear, vocal
cord, brain, and temporal lobe of the brain. Some institutions
excluded the deep lobe of the parotid gland from the struc-
tures to be spared, especially in the involved side (Fig. 2).
Only two institutions used the planning at risk volume (PRV),
which is expanded with margins ranging from 2 to 3 mm
from contoured normal tissues such as lens, brainstem, and
spinal cord. 
All institutions used the so-called ‘pseudo-target’ structure
ROI, region of interest; GTV, gross tumor volume; LN, lymph node; PTV,
planning target volume.
Volume of ROIs (cm
3)
GTV, 
primary
Institu-
tions
Cases
Institutions Cases
GTV, 
LNs
PTV1 PTV2 PTV3
Case 1 1 26.4 10.2 120.2 617.7 189.0
2 13.8 11.7 61.0 330.8 112.2
3 28.5 8.9 161.8 241.6 61.1
4 24.6 5.4 133.8 277.4 214.1
5 33.3 5.8 112.2 214.1 -
Case 2 1 69.6 52.9 296.1 689.9 -
2 46.6 86.5 234.6 499.3 147.7
3 35.8 47.4 253.4 330.7 287.1
4 35.9 47.3 466.2 210.7 -
5 53.4 224.9 223.9 223.9 -
Table 1. Variation in contouring among participating institutions
LN, lymph node; PTV, planning target volume.
Ipsilateral LN level
Level of the neck nodal area
12345
Contralateral LN level
123 4 5
Case 1 1
2
3
4
5
Case 2 1
2
3
4
5
Table 2. Variation in PTV delineation among participating institutions
- PTV1 PTV2 - PTV3
PTV2 PTV1 PTV3 - PTV3
PTV2 PTV1 PTV2 PTV3 PTV2 - PTV2 PTV3 --
PTV2 PTV1 PTV2 PTV3 PTV2 - PTV2 PTV3 --
- PTV1 PTV2 - PTV2 - PTV2 ---
PTV2 PTV1 PTV3 PTV2 PTV2 PTV1 PTV2 PTV3
- PTV1 PTV2 - PTV2 --
PTV2 PTV1 PTV2 PTV2 PTV1 PTV3
PTV1 PTV2 PTV1 PTV2
PTV2 PTV1 PTV2 PTV2 PTV1 PTV2Comparison of IMRT Planning Strategies 251
around the PTV to enhance dose conformity or normal tis-
sue avoidance while performing optimization. Differing num-
ber of variously shaped pseudo-targets were used: global, local,
or both (Table 3, Fig. 3). 
Planning parameters
Wide variation also existed in the setting of planning para-
meters (Table 4). Only one institution used the split-field
IMRT technique, in which the low anterior neck is treated
with an anterior field and matched with the IMRT portion.
All of the others used extended whole-field IMRT, in which
all of the target volumes are included within the IMRT field.
The number of employed beams ranged from 7 to 11. All
institutions used coplanar beams with equally spaced angles. 
The p3-IMRT inverse planning module of Pinnacle3 pro-
vides two different methods for prescribing constraints for
optimization. A hard constraint is the maximum or mini-
mum dose for a ROI to be met absolutely while optimizing
beam intensity, whereas a DVH constraint is the dose pre-
scribed to a certain percentage of ROI volume that can be
bargained using a weighting factor for each constraint. Only
one institution applied hard constraints. The number of pre-
scribed constraints ranged from 7 to 29, with a variety of
weighting factors applied for each constraint.
Dose statistics and biologic indices
The general features of the planning results are presented in
Table 5. The number of MUs planned to be delivered showed
wide variability: 466-1,134 in Case 1 and 490-2,269 in Case
2. MU was normalized for 90% of PTV1 to be covered with
Fig. 1. Variation in the delineation of GTV (A), PTV1 (B), PTV2 (C)
among institutions.
Color key: red, institution 1; green, institution 2; blue, institution 3;
yellow, institution 4; magenta, institution 5.
GTV, gross tumor volume; PTV, planning target volume. 
A
C
B PTV1, Case 1 PTV1, Case 2
GTV, Case 1 GTV, Case 2
PTV2, Case 1
PTV2, Case 2
Fig. 2. Variation in the parotid gland delineation among institutions. 
Color key: red, institution 1; green, institution 2; blue, institution 3;
yellow, institution 4; magenta, institution 5.
Fig. 3. Types of delineated pseudo-targets. 
Case 1 Case 2
Global type Local type
Number of pseudo-target utilized
Global pseudo-
target
Cases Institu-
tions Localized pseudo-
target
Case 1 1 0 1
21 1
32 0
42 0
52 1
Case 2 1 0 1
21 2
32 0
41 0
52 0
Table 3. Variation in utilization of a pseudo-target among par-
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70 Gy in Institution 2, and for 50% in Institution 5. The
other institutions did not normalize MU for target coverage.
The maximum dose ranged from 72.7 to 90.1 Gy in Case 1
and from 74.7 to 167.8 Gy in Case 2. The skin was the loca-
tion of maximum dose in half of the plans assessed. The in-
homogeneity index of PTV dose ranged from 4 to 49% in
Case 1, and from 5 to 46% in Case 2. The percentage devia-
tion of D50 from the dose of the planning goal was greater
in PTV2 and PTV3 than in PTV1. 
Because the individual institution’s ROIs and the employed
planning parameters were different for each institution, there
was a striking range in the distribution of isodose curves and
the DVH (Fig. 4, 5). The resulting plans by Institutions 1
and 2 showed excess dose deposit in the skin, oral cavity, and
the soft tissues in the neck. The inferior border of the retro-
pharyngeal lymph node was insufficiently covered in Insti-
tution 5. DVH for PTV2 showed that some institutions
failed to obtain a sharp dose fall-off at the border between
DVH, dose volume histogram.
Beam arrangement
Number of 
beams
Arrange-
ment
Cases Institu-
tions
Split 
vs.
extended
field
Case 1 1 Extended 7 Equiangular 16 13
2 Split 9 Equiangular 0 12
3 Extended 9 Equiangular 0 7
4 Extended 9 Equiangular 0 7
5 Extended 7 Equiangular 0 12
Case 2 1 Extended 9 Equiangular 15 9
2 Split 9 Equiangular 0 13
3 Extended 9 Equiangular 0 8
4 Extended 11 Equiangular 0 11
5 Extended 7 Equiangular 0 13
Table 4. Variation in the planning parameters utilized among
participating institutions
Number of 
constraints
Hard DVH
ROI, region of interest; MU, monitor unit; Max., maximum; PTV, planning target volume; D50, the dose where the cumulative DVH intersects with 50%
of the volume; DVH, dose volume histogram.
Cases
Institu-
tions
Total MU
MU 
normalize
Max. dose
(Gy)
Location of
max. dose
Deviation of D50
from planning goal (%)
PTV1 PTV2 PTV3
Homogeneity index
PTV1 PTV2 PTV3
Case 1 1 893 No 82.3 PTV1 0.17 0.26 0.17 +4.0 +6.6 +3.9
2 1,134 Yes 90.1 Skin 0.07 0.24 0.49 +2.4 +7.6 +5.8
3 466 No 72.7 Muscle 0.08 0.12 0.04 -2.1 -1.2 -1.4
4 599 No 77.6 Skin 0.07 0.10 0.05 -1.3 -0.7 -0.4
5 638 Yes 80.4 Skin 0.04 0.18 - +0.6 +5.6 -
Case 2 1 1,281 No 167.8 Skin 0.14 0.46 - +7.4 +17.2 -
2 2,269 Yes 123.2 Skin 0.10 0.18 0.22 +3.1 +10.9 +13.8
3 490 No 75.2 PTV1 0.08 0.11 0.05 -1.9 +0.2 -0.4
4 559 No 79.4 Vertebrae 0.14 0.15 - -1.3 -1.9 -
5 593 Yes 74.7 PTV1 0.05 0.17 - -1.1 +4.0 -
Table 5. General features of the planning results
Fig. 4. Variation of isodose distribution
among participating institutions (Case 2). Comparison of IMRT Planning Strategies 253
PTV1 and PTV2, and that the high-dose area in PTV2 was
even hotter than that in PTV1 in one institution. 
For given clinical cases, the dose statistics showing IMRT
dose delivery patterns showed marked variations for both of
standard ROIs and individual institution’s ROIs among insti-
tutions (Table 6). The values of D95 for PTV1 were less than
the prescribed dose in all plans. In Institution 1, D5 for PTV1
was more than 110% of the prescribed dose. The sparing of
the parotid glands was tightest in Institution 5, with consid-
eration that Institution 5 delineated the deep lobe on both
sides. The other institutions tried to spare at least one parotid
gland, located at the contralateral side of the primary tumor.
D5 values for the spinal cord exceeded 45 Gy in one institu-
tion for standard ROI and in two institutions for individual
institution’s ROI. The value of D5 for brainstem exceeded
54 Gy in one institution. 
In contrast to the profound variations recorded in dose
statistics for PTV, variation in TCP for the primary lesion
and involved lymph nodes was not so pronounced for both
standard ROIs and individual institution’s ROIs (Table 7).
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Fig. 5. Variation of the dose volume histogram for planning target volumes among participating institutions (Case 2).
Color key: red, institution 1; green, institution 2; blue, institution 3; yellow, institution 4; magenta, institution 5.
ROI, region of interest; PTV, planning target volume; D95, the dose where the cumulative DVH intersects with 95% of the volume; D50, the dose where the
cumulative DVH intersects with 50% of the volume; D5, the dose where the cumulative DVH intersects with 5% of the volume; DVH, dose volume his-
togram.
ROIs
Institu-
tions
PTV1
D95 (Gy) D50 (Gy) D5 (Gy) D95 (Gy) D50 (Gy) D5 (Gy) D50 (Gy) D50 (Gy) D5 (Gy) D5 (Gy)
PTV2
Parotid, 
right
Parotid, 
left
Brain-
stem
Spinal
cord
Standard 1 65.8 73.3 79.2 52.6 64.5 71.9 38.7 25.8 49.6 41.6
ROIs 2 56.6 70.4 73.6 47.1 61.6 69.1 50.8 37.1 61.5 46.2
3 67.0 69.3 70.6 54.5 59.4 68.7 44.2 25.0 46.5 37.6
4 64.3 69.4 71.2 56.0 59.4 68.8 35.5 20.4 41.3 35.2
5 69.2 70.7 72.0 59.0 61.7 70.0 25.7 23.1 43.9 37.8
Institution’s 1 66.3 73.3 79.1 54.5 64.5 71.2 39.9 25.8 51.2 50.4
ROIs 2 68.7 72.4 73.9 54.2 64.7 69.9 48.5 35.9 - 46.0
3 65.3 69.1 70.6 55.6 59.0 62.5 34.1 23.9 47.2 37.4
4 66.5 69.5 71.3 56.3 59.2 62.4 35.8 20.7 41.2 34.3
5 69.2 70.7 72.0 59.0 61.7 70.0 25.7 23.1 43.9 37.8
Table 6. Dose statistics for standard ROIs and each institution’s ROIs (Case 1)
ROI, region of interest; TCP, tumor control probability; NTCP, normal
tissue complication probability; GTV, gross tumor volume.
TCP (%)
GTV,
primary 
lesion
GTV,
involved
lymph
nodes
NTCP (%)
Skin Parotid,
left
Parotid,
right
Cases Institu-
tions
Standard 1 99 100 45 2 14
ROIs 2 90 100 78 14 26
3 95 100 52 4 2
4 96 100 25 1 2
5 97 100 11 2 3
Institution’s 1 99 100 52 2 -
ROIs 2 99 100 51 10 -
3 95 100 24 2 -
4 96 100 23 1 -
5 97 100 11 2 -
Table 7. Biological indices for standard ROIs and each institu-
tion’s ROIs (Case 1)The NTCP for parotid glands and skin was largely unsatis-
factory, showing marked variation among institutions. Con-
sidering the trend to sacrifice the parotid gland of the in-
volved side, the NTCP for the contralateral side still showed
unsatisfactory results in some institutions. Excess dose deliv-
ery to the skin, as shown in Fig. 4, explains the high NTCP
of the skin in Institutions 1 and 2.
DISCUSSION
In Korea, IMRT is in the early stage of implementation,
with routine use limited to a small number of hospitals; how-
ever, more hospitals are being equipped with modern state-
of-the-art IMRT technology (10). Some institutions in Korea
have performed the planning studies and explored the feasi-
bility of IMRT in the clinical settings (3, 4, 11-13). The Kore-
an Radiation Oncology Group (KROG) is currently per-
forming a study regarding the optimal radiation prescrip-
tion using IMRT in applying simultaneous integrated boost
for nasopharyngeal cancer (KROG-0501). 
Early publications on IMRT for head and neck cancer sug-
gested significant heterogeneity in global head and neck
IMRT practice patterns (17). For the same prescribed target
dose and dose constraints for organ at risk, IMRT strategies
in the study showed striking difference in various aspects,
such as beam setup, total number of segments, PTV dose
coverage and dose statistics for organs at risks. This Euro-
pean Society for Therapeutic Radiology and Oncology (ES-
TRO) planning exercise demonstrated that the planning of
IMRT needs close cooperation between the various disci-
plines involved in the preparation and execution of a treat-
ment. 
It is believed that much of the heterogeneity in IMRT arises
from physician-based factors. Clearly, radiation oncologists
should receive sound training in those factors determined
by the physician in performing IMRT, including target delin-
eation, setting of parameters for objective functions, inter-
pretation of the resultant plan, and understanding of uncer-
tainties in delivery. It appears that there exists a lack of pre-
paredness for fully implementing IMRT as a clinical routine
in Korea. This study was therefore undertaken to assess the
pattern of planning strategies for head and neck IMRT plan-
ning, with particular emphasis on physician-based factors
such as identifying the target volume and non-tumor tissues
on the planning CT, and specifying the dose to the target
volume and the surrounding normal organs. 
The factors such as RTPS, its optimization algorithm, beam
data, and other physical QA-related issues were identically
controlled, meaning that physician-related factors in IMRT
planning (e.g., target segmentation and the prescription for
inverse planning) have a greater influence on the resulting
plan quality than QA issues in the delivery of complex IMRT
plan. Although physical QA issues are also important, physi-
cian-based factors in IMRT planning are critical, and must
undergo preparation before state-of-the art IMRT technolo-
gy can be implemented in the clinical setting. 
The present study identified marked variations in IMRT
design and global patterns of planning strategies for IMRT
of nasopharyngeal cancer in Korea. Substantial variations
existed not only in target definition and dose prescription,
but also with regard to the management of neck node areas;
consequently, the resultant IMRT plans were strikingly dif-
ferent among the institutions. The variation in volume seg-
mentation translated into the variation of dose statistics for
standard ROIs. However, the dose statistics for individual
institution’s ROIs also showed substantial variation among
institutions. This indicates that the difference of planning
quality originates not only from the difference of ROI delin-
eation but from the ability to perform inverse planning.
One of the shortcomings of the current study is that target
volume determination guidelines and plan acceptance guide-
lines were not provided to each institution participated. It
was remained to each institution’s discretion. The IMRT could
not be planned with only condition of doses of PTV1, PTV2
and PTV3 and without target determination guideline, accep-
tance criteria and so on. The marked variations in IMRT de-
sign and global patterns of planning results shown in the
current study are not only due to the quality of IMRT plan-
ning in each institution but because of the lack of precise
guideline while performing the IMRT planning. However,
the institutions participated are in substantial agreement
that the cause of wide variation of planning results are main-
ly due to variation of physician-based factors such as volume
segmentation and setting the parameters for inverse planning.
This wide variation could potentially be translated into dif-
ferent treatment outcomes between each institution. 
Preparedness in performing IMRT is a crucial factor in its
implementation. In the present study, the planning results
of Institution 1 and 2 were relatively difficult to brag out. At
the time of this planning study, Institution 1 and 2 did not
performed IMRT for clinical cases. The attainment of excel-
lence in IMRT practice requires greater effort in terms of
time, man-power, and education, among other factors. Given
the growing popularity of IMRT, it is not surprising that
numerous IMRT ‘‘schools’’, seminars, and workshops have
appeared internationally. However, there are few education-
al opportunities available for participating radiation oncolo-
gists in Korea. The human resources available to the KOS-
TRO radiation oncology society remain limited (10). 
It is also necessary to support efforts to develop ‘class-solu-
tion’, in which an automated inverse planning protocol using
a single set of inverse-planning parameters can be used for
most patients to generate an acceptable IMRT plan. This
would eliminate the need for time-consuming user-interface
optimization in most cases. The adoption of computer-based
assistance for physician factors in IMRT is also desirable (18). 
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